First AD

Second AD

Oncology Business Management

 Oncology Business Management condition center page is a comprehensive resource for news and expert insights on business-focused updates and topics in oncology practices, including diversity efforts, telehealth, gaps in care, payment models, and more. This page features news articles, interviews in written and video format, and podcasts that focus on updates and best practices with oncology business management.

FDA Approves MM-398, T-VEC, and Trabectedin, Cabozantinib RCC FDA Submission Started, New Pembrolizumab Data, and More